ストックスクリーナーアプリを入手
115.19
0.11%
0.13
アフターアワーズ：
115.19
前日終値:
$115.06
開ける：
$116.61
24時間の取引高:
799.82K
Relative Volume:
0.74
時価総額：
$6.50B
収益：
$738.26M
当期純損益:
$48.89M
株価収益率:
133.24
EPS:
0.8645
ネットキャッシュフロー:
$91.69M
1週間 パフォーマンス:
+6.15%
1か月 パフォーマンス:
-2.05%
6か月 パフォーマンス:
-32.71%
1年 パフォーマンス:
-2.51%
1日の値動き範囲:
$112.41
$117.00
1週間の範囲:
$103.63
$117.00
52週間の値動き範囲:
$100.99
$175.77
Repligen Corp Stock (RGEN) Company Profile
Compare RGEN vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
115.19 | 6.49B | 738.26M | 48.89M | 91.69M | 0.8645 |
ISRG
Intuitive Surgical Inc
|
436.64 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.75 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.70 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.16 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
207.98 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-17 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-10-01 | 開始されました | HSBC Securities | Buy |
| 2025-09-22 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-22 | 再開されました | Stephens | Overweight |
| 2025-06-24 | 開始されました | Barclays | Overweight |
| 2025-04-29 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | 開始されました | Evercore ISI | In-line |
| 2025-02-10 | 開始されました | TD Cowen | Buy |
| 2024-12-17 | 開始されました | Canaccord Genuity | Hold |
| 2024-11-14 | 開始されました | Wolfe Research | Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-26 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-06-18 | 開始されました | Guggenheim | Neutral |
| 2023-12-04 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-07-20 | 開始されました | Wells Fargo | Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-03-28 | 開始されました | The Benchmark Company | Buy |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | 開始されました | UBS | Buy |
| 2021-10-14 | 開始されました | Exane BNP Paribas | Outperform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-07 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-11-01 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | 開始されました | SVB Leerink | Outperform |
| 2019-08-28 | 繰り返されました | First Analysis Sec | Outperform |
| 2019-08-23 | 再開されました | Stephens | Overweight |
| 2019-07-22 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | アップグレード | CL King | Neutral → Buy |
| 2018-11-12 | ダウングレード | CL King | Buy → Neutral |
| 2018-09-26 | 開始されました | H.C. Wainwright | Neutral |
| 2017-12-08 | 開始されました | Citigroup | Buy |
| 2017-12-05 | 開始されました | JP Morgan | Overweight |
| 2017-11-13 | 開始されました | CL King | Buy |
| 2017-10-02 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | 開始されました | William Blair | Outperform |
| 2017-02-13 | アップグレード | Piper Jaffray | Neutral → Overweight |
すべてを表示
Repligen Corp (RGEN) 最新ニュース
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference - Yahoo Finance
Repligen Corp stock (US7607591002): ESG progress and growth focus draw fresh attention - AD HOC NEWS
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks - Yahoo Finance
Repligen keeps factories on 100% renewable power, cuts water use 14% - Stock Titan
Repligen Corp (RGEN) Stock Up 4.2% and Still Undervalued -- GF S - GuruFocus
Repligen shares jump 4.1% as investors buy the dip after a sharp selloff; prior guidance update and short-covering may be factors - Quiver Quantitative
Repligen Jumps 5.4% Amid Sector-Wide Rally - AlphaStreet
Why Repligen (RGEN) Stock Is Trading Up Today - Yahoo Finance
Repligen (RGEN) director granted RSUs and options in Form 4 filing - Stock Titan
Repligen (NASDAQ: RGEN) director receives new RSU and stock option awards - Stock Titan
Repligen (RGEN) director Rohin Mhatre receives RSU and option grants - Stock Titan
Repligen (RGEN) director Margaret Pax receives new RSU and stock option awards - Stock Titan
Repligen (RGEN) director granted RSUs and stock options as compensation - Stock Titan
Repligen (RGEN) director receives new RSU and stock option grants - Stock Titan
Repligen Corp stock (US7607591002): bioprocessing specialist back in focus after latest earnings - AD HOC NEWS
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know - Yahoo Finance
Repligen Corp stock (US7607591002): RBC upgrade and Q1 2026 earnings put bioprocessing specialist ba - AD HOC NEWS
BNY Mellon Mid Cap Multi-Strategy Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Repligen Corp. 2026 Annual Meeting Results: Voting Outcomes & Key Shareholder Decisions - Minichart
Repligen shareholders approve board nominees and executive pay at annual meeting - Investing.com
Repligen (NASDAQ: RGEN) holders back board, auditor and pay plan - Stock Titan
5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call - Yahoo Finance
Repligen (RGEN) Receives Positive Coverage from RBC Capital - GuruFocus
Repligen stock coverage resumed at RBC with outperform rating By Investing.com - Investing.com Nigeria
Repligen stock coverage resumed at RBC with outperform rating - Investing.com
Repligen Corp stock (US7607591002): bioprocessing specialist after earnings and 52?week low - AD HOC NEWS
Repligen CorporationCommon Stock (NQ: RGEN - FinancialContent
Repligen Corp (RGEN) Stock Down 5.8% -- Now Undervalued? GF Scor - GuruFocus
Repligen Corporation stock hits 52-week low at $109.44 - Investing.com
Repligen Opens Bioprocessing Innovation Center in the Netherlands - HarianBasis.co
Barclays Maintains an “Overweight Rating” on Repligen Corporation (RGEN) - Insider Monkey
TradingKey - TradingKey
Repligen Q1 2026 slides: revenue jumps 15%, China sales double - Investing.com
Earnings call transcript: Repligen’s Q1 2026 results exceed expectations - Investing.com
Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus
Repligen (RGEN) director adds 2,434 shares via option exercise - Stock Titan
Repligen (RGEN) CPO has 334 RSU shares withheld to cover taxes - Stock Titan
Investors can watch Repligen CFO live from a May 12 healthcare conference - Stock Titan
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference - Yahoo Finance
Repligen (NASDAQ: RGEN) posts Q1 2026 growth but books Polymem sale loss - Stock Titan
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises - Yahoo Finance
Repligen Corporation (NASDAQ:RGEN) Q1 2026 Earnings Call Transcript - Insider Monkey
Repligen Reshapes Operations And China Reach As Valuation Signals Upside - Yahoo Finance
Repligen Q1 Earnings Call Highlights - Yahoo Finance
Repligen Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Repligen (RGEN) Shares Skyrocket, What You Need To Know - Barchart.com
Repligen (RGEN) Q1 2026 Earnings Call Transcript - The Globe and Mail
Repligen Q1 2026 slides: analytics surge drives 23% EPS growth - Investing.com
Earnings call transcript: Repligen beats Q1 2026 forecasts, stock rises By Investing.com - Investing.com Canada
Earnings call transcript: Repligen beats Q1 2026 forecasts, stock rises - Investing.com
Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Repligen Corp (RGEN) 財務データ
収益
当期純利益
現金流量
EPS
Repligen Corp (RGEN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Loeillot Olivier | Chief Executive Officer |
Apr 21 '26 |
Sale |
140.00 |
3,832 |
536,480 |
54,246 |
1.04%
0.04%
大文字化:
|
ボリューム (24 時間):